A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 591,05 kr, with a 24-hour trading volume of 3,54B kr. The asset's market cap is 2,46T kr, after moving 0.01% in the last day.
Tokenized AstraZeneca PLC is trading at 894,42 kr, with a tokenized market cap of 506,4M kr and a 24-hour trading volume of 7,07M kr. The tokenized asset has moved -3.65% in the past 24 hours.